Dealings in Securities by Directors Ascendis Health Limited (Registration number 2008/005856/06) (Incorporated in the Republic of South Africa) Share Code: ASC ISIN: ZAE000185005 ('Ascendis' or 'the company') Dealings in Securities by Directors In terms of paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements ("the Listings Requirements"), the following information relating to dealings in securities by directors is disclosed: Directors: Gary Shayne and Crispian Dillon, non-executive directors Class of share: Ordinary shares Nature of transaction: Purchase on market Nature of interest: Indirect beneficial, Coast2Coast Capital Proprietary Limited Group Date of transaction: 14 December 2017 Number of shares: 250,000 shares Purchase price per share (low): R14.95 Purchase price per share (high): R16.19 Volume weighted average price: R15.4424 Total value of transaction: R3,860,590.12 Date of transaction: 15 December 2017 Number of shares: 270,000 shares Purchase price per share (low): R14.86 Purchase price per share (high): R15.21 Volume weighted average price: R14.9891 Total value of transaction: R4,047,056.85 Clearance in terms of paragraph 3.66 of the Listings Requirements has been obtained from the Chairman of the Board. 18 December 2017 Johannesburg Sponsor Investec Bank Limited Date: 18/12/2017 02:35:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.